Application Videos
Take a tour of Crystec’s technology in action through our collection of videos.
mSAS® for Improved Dissolution
From identifying alternative solid-state forms and reducing particle size, to generating combination particles and scalable co-crystals, watch our video to see how Crystec's mSAS® technology can be applied to increase rates of dissolution and enhance bioavailability.
mSAS® for Optimised Inhaled Delivery
Through control of particle size and shape, and smooth, low-energy surfaces, mSAS® particles demonstrate impressive aerodynamic performance. This enables high levels of lung deposition from simple, off-the-shelf devices, reducing both drug and device development timelines. This video is a visual comparison of the aerosolisation ability of mSAS® vs micronised particles.
From Active Ingredient to Performance Medicine
Crystec’s mSAS® technology can be applied across a range of molecule classes (e.g. small molecules, biotherapeutics, natural products and mixtures). For natural products and difficult to crystallise materials, a key advantage of mSAS® is the ability to rapidly extract residual solvents and impurities, resulting in dry, free flowing powders, often with enhanced physical and chemical stability.
mSAS® Particle Engineering vs. Conventional Micronisation
mSAS® particles are generated using a single-step, ‘bottom-up’ process, providing uniform particles with smooth, low energy surfaces, ultimately enabling the development of free-flowing powders that are less cohesive than their micronised equivalents.